Bovine Lactoferrin Inhibits Dengue Virus Infectivity by Interacting with Heparan Sulfate, Low-Density Lipoprotein Receptor, and DC-SIGN

Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue virus (DENV) infection. In this study, we evaluated the antiviral effect of bLF against DENV infection in vivo and in vitro. Bovine LF signifi...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 18; no. 9; p. 1957
Main Authors Chen, Jo-Mei, Fan, Yi-Chin, Lin, Jen-Wei, Chen, Yi-Ying, Hsu, Wei-Li, Chiou, Shyan-Song
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 12.09.2017
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue virus (DENV) infection. In this study, we evaluated the antiviral effect of bLF against DENV infection in vivo and in vitro. Bovine LF significantly inhibited the infection of the four serotypes of DENV in Vero cells. In the time-of-drug addition test, DENV-2 infection was remarkably inhibited when bLF was added during or prior to the occurrence of virus attachment. We also revealed that bovine LF blocks binding between DENV-2 and the cellular membrane by interacting with heparan sulfate (HS), dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN), and low-density lipoprotein receptors (LDLR). In addition, bLF inhibits DENV-2 infection and decreases morbidity in a suckling mouse challenge model. This study supports the finding that bLF may inhibit DENV infection by binding to the potential DENV receptors.
AbstractList Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue virus (DENV) infection. In this study, we evaluated the antiviral effect of bLF against DENV infection in vivo and in vitro. Bovine LF significantly inhibited the infection of the four serotypes of DENV in Vero cells. In the time-of-drug addition test, DENV-2 infection was remarkably inhibited when bLF was added during or prior to the occurrence of virus attachment. We also revealed that bovine LF blocks binding between DENV-2 and the cellular membrane by interacting with heparan sulfate (HS), dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN), and low-density lipoprotein receptors (LDLR). In addition, bLF inhibits DENV-2 infection and decreases morbidity in a suckling mouse challenge model. This study supports the finding that bLF may inhibit DENV infection by binding to the potential DENV receptors.Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue virus (DENV) infection. In this study, we evaluated the antiviral effect of bLF against DENV infection in vivo and in vitro. Bovine LF significantly inhibited the infection of the four serotypes of DENV in Vero cells. In the time-of-drug addition test, DENV-2 infection was remarkably inhibited when bLF was added during or prior to the occurrence of virus attachment. We also revealed that bovine LF blocks binding between DENV-2 and the cellular membrane by interacting with heparan sulfate (HS), dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN), and low-density lipoprotein receptors (LDLR). In addition, bLF inhibits DENV-2 infection and decreases morbidity in a suckling mouse challenge model. This study supports the finding that bLF may inhibit DENV infection by binding to the potential DENV receptors.
Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue virus (DENV) infection. In this study, we evaluated the antiviral effect of bLF against DENV infection in vivo and in vitro. Bovine LF significantly inhibited the infection of the four serotypes of DENV in Vero cells. In the time-of-drug addition test, DENV-2 infection was remarkably inhibited when bLF was added during or prior to the occurrence of virus attachment. We also revealed that bovine LF blocks binding between DENV-2 and the cellular membrane by interacting with heparan sulfate (HS), dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN), and low-density lipoprotein receptors (LDLR). In addition, bLF inhibits DENV-2 infection and decreases morbidity in a suckling mouse challenge model. This study supports the finding that bLF may inhibit DENV infection by binding to the potential DENV receptors.
Author Chen, Jo-Mei
Lin, Jen-Wei
Chiou, Shyan-Song
Hsu, Wei-Li
Fan, Yi-Chin
Chen, Yi-Ying
AuthorAffiliation Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan; chenjm0317@gmail.com (J.-M.C.); yichinfan0309@gmail.com (Y.-C.F.); provista.wei@gmail.com (J.-W.L.); irisgf1986@gmail.com (Y.-Y.C.); wlhsu@dragon.nchu.edu.tw (W.-L.H.)
AuthorAffiliation_xml – name: Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan; chenjm0317@gmail.com (J.-M.C.); yichinfan0309@gmail.com (Y.-C.F.); provista.wei@gmail.com (J.-W.L.); irisgf1986@gmail.com (Y.-Y.C.); wlhsu@dragon.nchu.edu.tw (W.-L.H.)
Author_xml – sequence: 1
  givenname: Jo-Mei
  surname: Chen
  fullname: Chen, Jo-Mei
– sequence: 2
  givenname: Yi-Chin
  surname: Fan
  fullname: Fan, Yi-Chin
– sequence: 3
  givenname: Jen-Wei
  surname: Lin
  fullname: Lin, Jen-Wei
– sequence: 4
  givenname: Yi-Ying
  surname: Chen
  fullname: Chen, Yi-Ying
– sequence: 5
  givenname: Wei-Li
  orcidid: 0000-0002-1392-163X
  surname: Hsu
  fullname: Hsu, Wei-Li
– sequence: 6
  givenname: Shyan-Song
  surname: Chiou
  fullname: Chiou, Shyan-Song
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28895925$$D View this record in MEDLINE/PubMed
BookMark eNptkk-PEyEYhydmjftHb54NiRcPHQWmMHAx0a7uNplo4qpXwjDvtDRTGIHppp_Ary3N7pq68QS8PL8nL-E9L06cd1AULwl-W1USv7ObbSQCSyJZ_aQ4I3NKS4x5fXK0Py3OY9xgTCvK5LPilAohmaTsrPj90e-sA9Rok3wPIViHlm5tW5siugS3mgD9tGGKudqDSXZn0x61-3xMEHLIuhW6tWmNrmHUQTt0Mw29TjBDjb8tsyEeAo0d_Rh8gqz_BgbG5MMMadehy0V5s7z68rx42ushwov79aL48fnT98V12Xy9Wi4-NKWZE5pKplsgkra1ILhumWBdzzrS94wxUwkDWDAuKe9bLroOak5ZLaWhrOpJPefSVBfF-zvvOLVb6Ay4FPSgxmC3OuyV11b9e-PsWq38TjFOBMc8C97cC4L_NUFMamujgWHQDvwUFZGVIKIWc5HR14_QjZ-Cy8_LFKOUCMFZpl4dd_S3lYc_ygC9A0zwMQbolbFJJ-sPDdpBEawOg6COByGHZo9CD97_4n8AmQy15w
CitedBy_id crossref_primary_10_1080_20013078_2020_1808281
crossref_primary_10_2147_IDR_S376401
crossref_primary_10_1080_19390211_2020_1834047
crossref_primary_10_3389_fimmu_2024_1402135
crossref_primary_10_3390_biomedicines9121896
crossref_primary_10_1051_medsci_2025025
crossref_primary_10_1080_10408398_2021_1895063
crossref_primary_10_3390_ijms22115799
crossref_primary_10_3390_v15030705
crossref_primary_10_15789_2220_7619_POL_1156
crossref_primary_10_3390_ijms25031842
crossref_primary_10_3390_v13071312
crossref_primary_10_3389_fcimb_2018_00388
crossref_primary_10_1016_j_cellin_2024_100196
crossref_primary_10_1016_j_jacl_2021_09_048
crossref_primary_10_1016_j_heliyon_2021_e08087
crossref_primary_10_1042_BST20170398
crossref_primary_10_1007_s00253_021_11267_1
crossref_primary_10_33380_2305_2066_2022_11_1_32_39
crossref_primary_10_3390_ph16101352
crossref_primary_10_1002_fsn3_3314
crossref_primary_10_1007_s00018_019_03138_w
crossref_primary_10_1007_s10238_022_00851_y
crossref_primary_10_1016_j_jbc_2024_107849
crossref_primary_10_3390_v11080704
crossref_primary_10_1016_j_lfs_2024_123340
crossref_primary_10_1007_s12011_023_03658_4
crossref_primary_10_1016_j_abb_2024_110171
crossref_primary_10_1186_s12985_024_02608_3
crossref_primary_10_3390_nu13030870
crossref_primary_10_1080_17460441_2022_2033205
crossref_primary_10_1007_s12602_024_10430_0
crossref_primary_10_3390_ph17081021
crossref_primary_10_3389_fimmu_2020_01221
crossref_primary_10_3390_nano14242018
crossref_primary_10_1016_j_sajb_2024_04_045
crossref_primary_10_1007_s10719_021_10029_5
crossref_primary_10_1042_BSR20240134
crossref_primary_10_1007_s10989_020_10072_0
crossref_primary_10_1016_j_micres_2022_127206
crossref_primary_10_3390_pharmaceutics14091862
crossref_primary_10_1038_s41467_024_48989_5
crossref_primary_10_22159_ijcpr_2022v14i3_1984
crossref_primary_10_3390_pharmaceutics15041056
crossref_primary_10_1038_s41467_024_44872_5
crossref_primary_10_3390_v16111692
crossref_primary_10_1002_ame2_12145
Cites_doi 10.1016/j.bbrc.2005.05.171
10.1016/j.antiviral.2005.03.005
10.1101/071571
10.1016/j.virol.2005.01.010
10.3390/v7020480
10.1016/S1386-6346(02)00088-8
10.1146/annurev.nu.15.070195.000521
10.1038/nm0897-866
10.1371/journal.pone.0021658
10.1016/j.antiviral.2005.10.006
10.1016/S1095-6433(99)00122-1
10.1111/imb.12334
10.1128/JVI.78.22.12647-12656.2004
10.1016/j.virol.2013.04.003
10.1016/S0304-4165(01)00222-7
10.1016/j.antiviral.2014.08.012
10.1159/000080882
10.1186/s12917-016-0878-2
10.1007/s004300050093
10.1128/CMR.3.4.376
10.1073/pnas.96.22.12766
10.1016/S0166-3542(01)00195-4
10.1084/jem.20021840
10.1124/jpet.116.239574
10.1128/JVI.79.5.3009-3015.2005
10.1006/viro.1999.9633
10.1371/journal.pntd.0001636
10.1046/j.1432-1033.2003.03715.x
10.1016/j.virol.2008.06.017
10.1016/j.virol.2009.01.043
10.1093/clinids/11.Supplement_4.S830
10.1074/jbc.M504337200
10.1053/jhep.2000.18713
10.1007/978-1-4757-9068-9_13
10.1016/j.antiviral.2011.07.002
10.1006/abbi.1995.1139
10.1111/j.1747-0285.2008.00715.x
ContentType Journal Article
Copyright Copyright MDPI AG 2017
2017 by the authors. 2017
Copyright_xml – notice: Copyright MDPI AG 2017
– notice: 2017 by the authors. 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
Q9U
7X8
5PM
DOI 10.3390/ijms18091957
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
CrossRef

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central Database Suite (ProQuest)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1422-0067
ExternalDocumentID PMC5618606
28895925
10_3390_ijms18091957
Genre Journal Article
GroupedDBID ---
29J
2WC
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
ESX
F5P
FRP
FYUFA
GNUQQ
GUQSH
GX1
HH5
HMCUK
HYE
IAO
IHR
IPNFZ
ITC
KQ8
LK8
M1P
M2O
M48
MODMG
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RNS
RPM
TR2
TUS
UKHRP
~8M
3V.
ABJCF
BBNVY
BHPHI
CGR
CUY
CVF
ECM
EIF
GROUPED_DOAJ
HCIFZ
KB.
M7P
M~E
NPM
PDBOC
7XB
8FK
K9.
MBDVC
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
Q9U
7X8
5PM
ID FETCH-LOGICAL-c412t-5abe192b78107b585df5d1ff555c38ce0856926fb68dde7625799c253f17469c3
IEDL.DBID M48
ISSN 1422-0067
1661-6596
IngestDate Thu Aug 21 17:56:06 EDT 2025
Mon Jul 21 11:05:21 EDT 2025
Fri Jul 25 20:17:51 EDT 2025
Wed Feb 19 02:42:39 EST 2025
Tue Jul 01 03:30:04 EDT 2025
Thu Apr 24 23:05:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords heparan sulfate
low-density lipoprotein receptor
DC-SIGN
bovine lactoferrin
dengue virus
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c412t-5abe192b78107b585df5d1ff555c38ce0856926fb68dde7625799c253f17469c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1392-163X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms18091957
PMID 28895925
PQID 1952218865
PQPubID 2032341
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5618606
proquest_miscellaneous_1938187848
proquest_journals_1952218865
pubmed_primary_28895925
crossref_citationtrail_10_3390_ijms18091957
crossref_primary_10_3390_ijms18091957
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-09-12
PublicationDateYYYYMMDD 2017-09-12
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-09-12
  day: 12
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2017
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Lonnerdal (ref_2) 1995; 15
Chen (ref_11) 1997; 3
Berges (ref_19) 2005; 333
Lozach (ref_13) 2005; 280
Henchal (ref_9) 1990; 3
Bouchard (ref_37) 2014; 111
Beleid (ref_4) 2008; 72
Harada (ref_36) 1999; 124
ref_31
Marchetti (ref_21) 1999; 187
Chien (ref_6) 2008; 379
ref_17
Schuller (ref_35) 2011; 92
Weng (ref_3) 2005; 67
ref_15
Legrand (ref_5) 2001; 1568
Pietrantoni (ref_22) 2006; 69
Hara (ref_23) 2002; 24
Kerr (ref_32) 2017; 361
Thepparit (ref_34) 2004; 78
Tassaneetrithep (ref_12) 2003; 197
ref_20
Beljaars (ref_1) 2001; 52
Jindadamrongwech (ref_33) 2004; 47
Hilgard (ref_27) 2000; 32
Pietrantoni (ref_24) 2015; 7
Alen (ref_14) 2009; 387
Agnello (ref_29) 1999; 96
Halstead (ref_8) 1989; 11
ref_26
Wu (ref_28) 1995; 317
Hung (ref_10) 1999; 257
Waarts (ref_16) 2005; 333
Huettinger (ref_18) 1998; 443
Groot (ref_7) 2005; 79
Kanyshkova (ref_25) 2003; 270
Mosso (ref_30) 2013; 442
12393024 - Hepatol Res. 2002 Nov;24(3):228
15564750 - Intervirology. 2004;47(6):370-3
11050058 - Hepatology. 2000 Nov;32(5):1069-77
2665015 - Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9
11675140 - Antiviral Res. 2001 Dec;52(3):225-39
15916817 - Antiviral Res. 2005 Jul;67(1):31-7
16386316 - Antiviral Res. 2006 Feb;69(2):98-106
15507651 - J Virol. 2004 Nov;78(22):12647-56
10535997 - Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12766-71
23642566 - Virology. 2013 Aug 1;442(2):132-47
21738755 - PLoS One. 2011;6(6):e21658
10665381 - Comp Biochem Physiol A Mol Integr Physiol. 1999 Nov;124(3):321-7
25193851 - Antiviral Res. 2014 Nov;111:13-22
19264337 - Virology. 2009 Apr 25;387(1):67-75
25643293 - Viruses. 2015 Jan 29;7(2):480-95
11786226 - Biochim Biophys Acta. 2001 Dec 19;1568(3):197-204
10208929 - Virology. 1999 Apr 25;257(1):156-67
18640695 - Virology. 2008 Sep 15;379(1):143-51
10363676 - Med Microbiol Immunol. 1999 May;187(4):199-204
28718976 - Insect Mol Biol. 2017 Jul 18;:null
27829421 - BMC Vet Res. 2016 Nov 10;12 (1):251
12899692 - Eur J Biochem. 2003 Aug;270(16):3353-61
9256277 - Nat Med. 1997 Aug;3(8):866-71
7872808 - Arch Biochem Biophys. 1995 Feb 20;317(1):85-92
15709021 - J Virol. 2005 Mar;79(5):3009-15
21763725 - Antiviral Res. 2011 Oct;92(1):96-101
15721362 - Virology. 2005 Mar 15;333(2):284-92
15963458 - Biochem Biophys Res Commun. 2005 Aug 5;333(3):896-907
28699858 - J Gen Virol. 2017 Jul;98 (7):1749-1754
28360334 - J Pharmacol Exp Ther. 2017 Jun;361(3):417-428
2224837 - Clin Microbiol Rev. 1990 Oct;3(4):376-96
12682107 - J Exp Med. 2003 Apr 7;197(7):823-9
22563515 - PLoS Negl Trop Dis. 2012;6(5):e1636
9781349 - Adv Exp Med Biol. 1998;443:107-11
19012577 - Chem Biol Drug Des. 2008 Nov;72(5):436-43
15855154 - J Biol Chem. 2005 Jun 24;280(25):23698-708
8527233 - Annu Rev Nutr. 1995;15:93-110
References_xml – volume: 333
  start-page: 896
  year: 2005
  ident: ref_19
  article-title: A cell line model for the differentiation of human dendritic cells
  publication-title: Biochemic. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2005.05.171
– volume: 67
  start-page: 31
  year: 2005
  ident: ref_3
  article-title: Lactoferrin inhibits enterovirus 71 infection by binding to vp1 protein and host cells
  publication-title: Antivir. Res.
  doi: 10.1016/j.antiviral.2005.03.005
– ident: ref_17
  doi: 10.1101/071571
– volume: 333
  start-page: 284
  year: 2005
  ident: ref_16
  article-title: Antiviral activity of human lactoferrin: Inhibition of alphavirus interaction with heparan sulfate
  publication-title: Virology
  doi: 10.1016/j.virol.2005.01.010
– volume: 7
  start-page: 480
  year: 2015
  ident: ref_24
  article-title: Bovine lactoferrin inhibits toscana virus infection by binding to heparan sulphate
  publication-title: Viruses
  doi: 10.3390/v7020480
– volume: 24
  start-page: 228
  year: 2002
  ident: ref_23
  article-title: Lactoferrin inhibits hepatitis b virus infection in cultured human hepatocytes
  publication-title: Hepatol. Res.
  doi: 10.1016/S1386-6346(02)00088-8
– volume: 15
  start-page: 93
  year: 1995
  ident: ref_2
  article-title: Lactoferrin: Molecular structure and biological function
  publication-title: Annu. Rev. Nutr.
  doi: 10.1146/annurev.nu.15.070195.000521
– volume: 3
  start-page: 866
  year: 1997
  ident: ref_11
  article-title: Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
  publication-title: Nat. Med.
  doi: 10.1038/nm0897-866
– ident: ref_15
  doi: 10.1371/journal.pone.0021658
– volume: 69
  start-page: 98
  year: 2006
  ident: ref_22
  article-title: Bovine lactoferrin peptidic fragments involved in inhibition of echovirus 6 in vitro infection
  publication-title: Antivir. Res.
  doi: 10.1016/j.antiviral.2005.10.006
– volume: 124
  start-page: 321
  year: 1999
  ident: ref_36
  article-title: Characteristic transport of lactoferrin from the intestinal lumen into the bile via the blood in piglets
  publication-title: Comp. Biochem. Physiol. Mol. Integr. Physiol.
  doi: 10.1016/S1095-6433(99)00122-1
– ident: ref_31
  doi: 10.1111/imb.12334
– volume: 78
  start-page: 12647
  year: 2004
  ident: ref_34
  article-title: Serotype-specific entry of dengue virus into liver cells: Identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor
  publication-title: J. Virol.
  doi: 10.1128/JVI.78.22.12647-12656.2004
– volume: 442
  start-page: 132
  year: 2013
  ident: ref_30
  article-title: The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in ldl particle uptake and hmg-coa reductase activity
  publication-title: Virology
  doi: 10.1016/j.virol.2013.04.003
– volume: 1568
  start-page: 197
  year: 2001
  ident: ref_5
  article-title: The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29–18-C1 cells is mediated through basic residues located in the N-terminus
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/S0304-4165(01)00222-7
– volume: 111
  start-page: 13
  year: 2014
  ident: ref_37
  article-title: The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune lactoferrin protein
  publication-title: Antivir. Res.
  doi: 10.1016/j.antiviral.2014.08.012
– volume: 47
  start-page: 370
  year: 2004
  ident: ref_33
  article-title: Virus overlay protein binding assay (vopba) reveals serotype specific heterogeneity of dengue virus binding proteins on hepg2 human liver cells
  publication-title: Intervirology
  doi: 10.1159/000080882
– ident: ref_26
  doi: 10.1186/s12917-016-0878-2
– volume: 187
  start-page: 199
  year: 1999
  ident: ref_21
  article-title: Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin
  publication-title: Med. Microbiol. Immunol.
  doi: 10.1007/s004300050093
– volume: 3
  start-page: 376
  year: 1990
  ident: ref_9
  article-title: The dengue viruses
  publication-title: Clin. Microbiol. Rev.
  doi: 10.1128/CMR.3.4.376
– volume: 96
  start-page: 12766
  year: 1999
  ident: ref_29
  article-title: Hepatitis c virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.96.22.12766
– volume: 52
  start-page: 225
  year: 2001
  ident: ref_1
  article-title: Antiviral activities of lactoferrin
  publication-title: Antivir. Res.
  doi: 10.1016/S0166-3542(01)00195-4
– volume: 197
  start-page: 823
  year: 2003
  ident: ref_12
  article-title: DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20021840
– volume: 361
  start-page: 417
  year: 2017
  ident: ref_32
  article-title: A genomic DNA reporter screen identifies squalene synthase inhibitors that act cooperatively with statins to upregulate the low-density lipoprotein receptor
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.116.239574
– volume: 79
  start-page: 3009
  year: 2005
  ident: ref_7
  article-title: Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the Dc-SIGN—gp120 interaction
  publication-title: J. Virol.
  doi: 10.1128/JVI.79.5.3009-3015.2005
– volume: 257
  start-page: 156
  year: 1999
  ident: ref_10
  article-title: Analysis of the steps involved in dengue virus entry into host cells
  publication-title: Virology
  doi: 10.1006/viro.1999.9633
– ident: ref_20
  doi: 10.1371/journal.pntd.0001636
– volume: 270
  start-page: 3353
  year: 2003
  ident: ref_25
  article-title: Multiple enzymic activities of human milk lactoferrin
  publication-title: Eur. J. Biochem.
  doi: 10.1046/j.1432-1033.2003.03715.x
– volume: 379
  start-page: 143
  year: 2008
  ident: ref_6
  article-title: Bovine lactoferrin inhibits japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein
  publication-title: Virology
  doi: 10.1016/j.virol.2008.06.017
– volume: 387
  start-page: 67
  year: 2009
  ident: ref_14
  article-title: Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection
  publication-title: Virology
  doi: 10.1016/j.virol.2009.01.043
– volume: 11
  start-page: S830
  year: 1989
  ident: ref_8
  article-title: Antibody, macrophages, dengue virus infection, shock, and hemorrhage: A pathogenetic cascade
  publication-title: Rev. Infect. Dis.
  doi: 10.1093/clinids/11.Supplement_4.S830
– volume: 280
  start-page: 23698
  year: 2005
  ident: ref_13
  article-title: Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M504337200
– volume: 32
  start-page: 1069
  year: 2000
  ident: ref_27
  article-title: Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes
  publication-title: Hepatology
  doi: 10.1053/jhep.2000.18713
– volume: 443
  start-page: 107
  year: 1998
  ident: ref_18
  article-title: The LDL-receptor family. Lactoferrin and lipid metabolism
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-1-4757-9068-9_13
– volume: 92
  start-page: 96
  year: 2011
  ident: ref_35
  article-title: Tripeptide inhibitors of dengue and west nile virus NS2B-NS3 protease
  publication-title: Antivir. Res.
  doi: 10.1016/j.antiviral.2011.07.002
– volume: 317
  start-page: 85
  year: 1995
  ident: ref_28
  article-title: Characterization of the glycosaminoglycan-binding region of lactoferrin
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1006/abbi.1995.1139
– volume: 72
  start-page: 436
  year: 2008
  ident: ref_4
  article-title: Helical peptides derived from lactoferrin bind hepatitis c virus envelope protein e2
  publication-title: Chem. Biol. Drug Des.
  doi: 10.1111/j.1747-0285.2008.00715.x
– reference: 15721362 - Virology. 2005 Mar 15;333(2):284-92
– reference: 23642566 - Virology. 2013 Aug 1;442(2):132-47
– reference: 19012577 - Chem Biol Drug Des. 2008 Nov;72(5):436-43
– reference: 28699858 - J Gen Virol. 2017 Jul;98 (7):1749-1754
– reference: 16386316 - Antiviral Res. 2006 Feb;69(2):98-106
– reference: 11675140 - Antiviral Res. 2001 Dec;52(3):225-39
– reference: 11786226 - Biochim Biophys Acta. 2001 Dec 19;1568(3):197-204
– reference: 12682107 - J Exp Med. 2003 Apr 7;197(7):823-9
– reference: 27829421 - BMC Vet Res. 2016 Nov 10;12 (1):251
– reference: 2224837 - Clin Microbiol Rev. 1990 Oct;3(4):376-96
– reference: 28718976 - Insect Mol Biol. 2017 Jul 18;:null
– reference: 2665015 - Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9
– reference: 21738755 - PLoS One. 2011;6(6):e21658
– reference: 25193851 - Antiviral Res. 2014 Nov;111:13-22
– reference: 10208929 - Virology. 1999 Apr 25;257(1):156-67
– reference: 19264337 - Virology. 2009 Apr 25;387(1):67-75
– reference: 9781349 - Adv Exp Med Biol. 1998;443:107-11
– reference: 9256277 - Nat Med. 1997 Aug;3(8):866-71
– reference: 10665381 - Comp Biochem Physiol A Mol Integr Physiol. 1999 Nov;124(3):321-7
– reference: 10363676 - Med Microbiol Immunol. 1999 May;187(4):199-204
– reference: 15855154 - J Biol Chem. 2005 Jun 24;280(25):23698-708
– reference: 15709021 - J Virol. 2005 Mar;79(5):3009-15
– reference: 22563515 - PLoS Negl Trop Dis. 2012;6(5):e1636
– reference: 15916817 - Antiviral Res. 2005 Jul;67(1):31-7
– reference: 15963458 - Biochem Biophys Res Commun. 2005 Aug 5;333(3):896-907
– reference: 28360334 - J Pharmacol Exp Ther. 2017 Jun;361(3):417-428
– reference: 21763725 - Antiviral Res. 2011 Oct;92(1):96-101
– reference: 8527233 - Annu Rev Nutr. 1995;15:93-110
– reference: 15507651 - J Virol. 2004 Nov;78(22):12647-56
– reference: 18640695 - Virology. 2008 Sep 15;379(1):143-51
– reference: 10535997 - Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12766-71
– reference: 12393024 - Hepatol Res. 2002 Nov;24(3):228
– reference: 12899692 - Eur J Biochem. 2003 Aug;270(16):3353-61
– reference: 25643293 - Viruses. 2015 Jan 29;7(2):480-95
– reference: 11050058 - Hepatology. 2000 Nov;32(5):1069-77
– reference: 15564750 - Intervirology. 2004;47(6):370-3
– reference: 7872808 - Arch Biochem Biophys. 1995 Feb 20;317(1):85-92
SSID ssj0023259
Score 2.4295554
Snippet Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1957
SubjectTerms Animals
Antiviral Agents - pharmacology
Cattle
Cell Adhesion Molecules - metabolism
Cell Line
Cercopithecus aethiops
Dengue - drug therapy
Dengue fever
Dengue Virus - drug effects
Female
Heparan sulfate
Heparitin Sulfate - metabolism
Humans
Infections
Inhibitory Concentration 50
Lactoferrin - pharmacology
Lectins, C-Type - metabolism
Low density lipoprotein
Mice
Mice, Inbred BALB C
Pregnancy
Receptors, Cell Surface - metabolism
Receptors, LDL - metabolism
Receptors, Virus - drug effects
THP-1 Cells
Vero Cells
Viral infections
Viral Plaque Assay
Virus Attachment - drug effects
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4t2FgowEJ2p1E8evE4IuZYuWXkrR3qLEjzaoOEuzEeov4G8zk2S3XRBcYzuJMvb4m_Hk-wh5VSDhSVJy5rgKLPOZZ8YFyfzYJt4WwYUu4fb5SE5Psk9zMR8Sbs1QVrnyiZ2jdrXFHPleYgApJFpL8Xbxg6FqFJ6uDhIaN8ktpC7Dki41vwq4eNqJpSWwBzEpjOwL3zmE-XvVt-8NUlfBKLW5Jf2FM_8sl7y2_xzcI3cH4Ejf9Za-T274-IDc7qUkLx-SX-8xNeDpDPVzAtItRnoYz6qyWjZ04uNp6-nX6qJt4GpXfoWaEbS8pF1KEP9uiKcUk7J06pEOPNLj9jwAEN2ls_onm2CdOwyYVYu6o3aA2wPi9AsI2XdpER2d7LPjw49Hj8jJwYcv-1M2iCwwmyXpkomi9IDySqUhECwheHBBuCQEIYTl2nqAZNKkMpRSgycE1ymUMTYVPEAsI43lj8lWrKPfJtTJsVaw4atClZnz3HBji1R4HrRLXJKNyJvVd87twECOQhjnOUQiaJX8ulVG5PW696Jn3vhHv52VyfJh_TX51WwZkZfrZlg5eBxSRF-32AfRitKZHpEnvYXXD0q1NsKkMFpt2H7dAVm5N1tiddaxcwtUIBjLp_9_rWfkTooAoROj2CFby4vWPwd4syxfdHP4N4OA_Bs
  priority: 102
  providerName: ProQuest
Title Bovine Lactoferrin Inhibits Dengue Virus Infectivity by Interacting with Heparan Sulfate, Low-Density Lipoprotein Receptor, and DC-SIGN
URI https://www.ncbi.nlm.nih.gov/pubmed/28895925
https://www.proquest.com/docview/1952218865
https://www.proquest.com/docview/1938187848
https://pubmed.ncbi.nlm.nih.gov/PMC5618606
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1bb9MwFD7aRUi8IO7LGJWR4IkFmotj-wEhtq7rUFchRlHfolzsLahzSy-C_gL-NuckTdQx9pKH-BLJx_b5jn3yfQCvEyI88dLAzQNh3FCH2lW5iVzdzjydJSY35YHb-SDqDcPPIz7aglptdD2A8_-GdqQnNZyN3_3-ufqIC_4DRZwYsr8vflzPiYbKU1xswy76JEFL9Dxs7hMQNnBVpb3fakF0wFIqrkgte9M33QKc_-ZNbjii7kN4sEaQ7FNl8kewpe1juFdpSq6ewJ8jOiPQrE9COoZ4Fy07s1dFWizmrKPt5VKz78VsOce3ZR4WiUewdMXKs0H6zcFeMjqdZT1NvOCWXSzHBhHpIetPfrkdSnjHBv1iOik5HrB7hJ56irH7IUtszjrH7sXZ6eApDLsn34577lptwc1Cz1-4PEk1wr1USIwIU4wicsNzzxjOeRbITCM2i5QfmTSSuCXiHsqFUpnPA4NBTaSy4Bns2InVe8DyqC0Fen6RiDTMdaAClSU-14GRuZd7oQNv63GOszUVOSlijGMMSchA8aaBHHjT1J5WFBx31DuoTRbX8yjGAh9RjIy4A6-aYlxCdC-SWD1ZUh2CLUKG0oHnlYWbD9VTwwFxw_ZNBaLnvllii6uSppuTFEE72r-zzxdw3yeQUApSHMDOYrbULxHiLNIWbIuRwKfsnrZg9-hk8OVri5wOb5Xz-i8zdQEw
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYIL4s2WAkaiJ2o1iWPHPiAEXcou3e6lLdpbmsR2G9Q6yz5U7S_g3_AbmUl2t10Q3HpN7LzGY38znnwfIW8zJDwJc84MTxyLbWyZNk4yGxShLTJnXJ1wO-jLznH8dSAGa-TX4l8YLKtczIn1RG2qAnPkO6EGpBAqJcWH4Q-GqlG4u7qQ0GiGxb6dXULINn7fbYN9t6Jo7_PRbofNVQVYEYfRhIkstwBr8kRB5JMDWjZOmNA5IUTBVWEBg0gdSZdLBa4Pc4VItC4iwR2Ad6kLDte9RW7DwhugRyWDqwCPR7U4WwhrHpNCy6bQnnMd7JTfL8ZIlQWvkawugX_h2j_LM6-td3sPyP05UKUfm5H1kKxZ_4jcaaQrZ4_Jz0-YirC0h3o9DukdPe36szIvJ2Patv50aum3cjQdw9G63As1Kmg-o3UKEv-m8KcUk8C0Y5F-3NPD6bkD4LtNe9Ula2NdPXTolcOqppKAywPCtcNJNdqmmTe0vcsOu1_6T8jxjXz-p2TdV94-J9TIQCUAMJIsyWNjuea6yCJhuVMmNGHcIu8W3zkt5oznKLxxnkLkg1ZJr1ulRbaWrYcN08c_2m0uTJbO_X2cXo3OFnmzPA2eitsvmbfVFNsgOkpUrFrkWWPh5Y0ipbTQEfROVmy_bIAs4KtnfHlWs4ELVDwI5Mb_H-s1uds5OuilvW5__wW5FyE4qYUwNsn6ZDS1LwFaTfJX9Xim5OSmHeg3uho39Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1db9MwFLXGEIgXxDeFAUZiT8xqE8eO_YAQrJSWlQppDPUtJLG9BQ2ntI2m_gL-E7-Oe5O2W0HwttfEztf1tc-9vjmHkBcpEp4EGWeGx45FNrJMGyeZ7eSBzVNnXJ1w-ziS_aPow1iMt8iv1b8wWFa5mhPridqUOebI24EGpBAoJUXbLcsiPnV7ryc_GCpI4U7rSk6jGSIHdnEG4dvs1aALtt4Nw967z_t9tlQYYHkUhHMm0swCxMliBVFQBsjZOGEC54QQOVe5BTwidShdJhVMAzBviFjrPBTcAZCXOudw3SvkasxFgD4Wj8-DPR7WQm0BrH9MCi2bonvOdaddfPs-Q9oseKV4czn8C-P-Wap5Ye3r3SI3l6CVvmlG2W2yZf0dcq2RsVzcJT_fYlrC0iFq9zikevR04E-KrJjPaNf648rSL8W0msHRuvQL9SpotqB1OhL_rPDHFBPCtG-RitzTw-rUAQjeo8PyjHWxxh46DItJWdNKwOUB7drJvJzu0dQb2t1nh4P3o3vk6FI-_32y7UtvHxJqZEfFADbiNM4iY7nmOk9DYblTJjBB1CIvV985yZfs5yjCcZpAFIRWSS5apUV2160nDevHP9rtrEyWLH1_lpyP1BZ5vj4NXotbMam3ZYVtECnFKlIt8qCx8PpGoVJa6BB6xxu2XzdARvDNM744qZnBBaofdOSj_z_WM3IdXCcZDkYHj8mNEHFKXTS3Q7bn08o-AZQ1z57Ww5mSr5ftP78BGUY8KQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bovine+Lactoferrin+Inhibits+Dengue+Virus+Infectivity+by+Interacting+with+Heparan+Sulfate%2C+Low-Density+Lipoprotein+Receptor%2C+and+DC-SIGN&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Chen%2C+Jo-Mei&rft.au=Fan%2C+Yi-Chin&rft.au=Lin%2C+Jen-Wei&rft.au=Chen%2C+Yi-Ying&rft.date=2017-09-12&rft.eissn=1422-0067&rft.volume=18&rft.issue=9&rft_id=info:doi/10.3390%2Fijms18091957&rft_id=info%3Apmid%2F28895925&rft.externalDocID=28895925
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon